Literature DB >> 10223909

Effectiveness and toxicity of gentamicin in an experimental model of pyelonephritis: effect of the time of administration.

M LeBrun1, L Grenier, P Gourde, M G Bergeron, G Labrecque, D Beauchamp.   

Abstract

Temporal variations in the renal toxicity of aminoglycosides have been reported for experimental animals as well as for humans. In fact, maximal renal toxicity of aminoglycosides was observed when the drug was given during the rest period, while a lower toxicity was observed when the drug was injected during the activity period. The aim of the present study was to evaluate temporal variations in the effectiveness and renal toxicity of gentamicin in an experimental model of pyelonephritis in rats. The experiments were carried out with female Sprague-Dawley rats (185 to 250 g). They had free access to food and water throughout the study and were maintained on a 14-h light-10-h dark cycle. Animals were divided into four groups corresponding to the respective time of induction of pyelonephritis and treatment: 0700, 1300, 1900, and 0100 h. Pyelonephritis was induced by a direct inoculation of Escherichia coli (10(7) to 10(8) CFU) in the left kidney. Animals were treated for 3 and 7 days with a single daily dose of gentamicin (20 and 40 mg/kg of body weight, respectively) or saline (NaCl, 0.9%) at either 0700, 1300, 1900, or 0100 h. Animals treated at 0100 h for 3 days with gentamicin (20 mg/kg) showed a significantly lower number of bacteria in their kidneys than did all other groups (P < 0.01). After 7 days of treatment, the efficacy, evaluated by the log CFU per gram of tissue and by the percentage of sterilized kidneys, was also higher when gentamicin was administered at 0100 h. The beta-galactosidase and the N-acetyl-beta-D-glucosaminidase activities were significantly higher in urine of rats given gentamicin at 1300 h than in urine of rats treated at another time of day (P < 0.05). Gentamicin injected at 1300 h induced a significantly greater increase of [3H]thymidine incorporation into DNA of renal cortex (P < 0.01), a significantly greater inhibition of sphingomyelinase activity (P < 0.05), and significantly more histopathological lesions than the same dose injected at another time of the day. Creatinine and blood urea nitrogen levels in serum were significantly higher (P < 0.05) and the creatinine clearance was significantly lower (P < 0.05) when gentamicin was injected at 1300 h than when it was injected at another time of day. Our data suggest temporal variations in both the toxicity and the effectiveness of gentamicin, the drug being more effective and less toxic when injected during the activity period of the animals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10223909      PMCID: PMC89106     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  44 in total

1.  Rapid colorimetric assay of beta-galactosidase and N-acetyl-beta-glucosaminidase in human urine.

Authors:  D Maruhn
Journal:  Clin Chim Acta       Date:  1976-12       Impact factor: 3.786

2.  A new method for the determination of gamma-glutamyltransferase in serum.

Authors:  J P Persijn; W van der Slik
Journal:  J Clin Chem Clin Biochem       Date:  1976-09

Review 3.  Acute dysuria in women.

Authors:  A L Komaroff
Journal:  N Engl J Med       Date:  1984-02-09       Impact factor: 91.245

4.  Circadian rhythms of urinary electrolyte excretion in freely moving rats.

Authors:  F Roelfsema; D van der Heide; D Smeenk
Journal:  Life Sci       Date:  1980-12-15       Impact factor: 5.037

5.  The effect of water diuresis on spread of bacteria through the urinary tract.

Authors:  D Kaye
Journal:  J Infect Dis       Date:  1971-09       Impact factor: 5.226

Review 6.  New approaches to the treatment of urinary tract infection.

Authors:  N E Tolkoff-Rubin; R H Rubin
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

7.  Increased renal DNA synthesis in vivo after administration of low doses of gentamicin to rats.

Authors:  G Laurent; P Maldague; M B Carlier; P M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

8.  Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin.

Authors:  G Laurent; M B Carlier; B Rollman; F Van Hoof; P Tulkens
Journal:  Biochem Pharmacol       Date:  1982-12-01       Impact factor: 5.858

Review 9.  Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982.

Authors:  G Kahlmeter; J I Dahlager
Journal:  J Antimicrob Chemother       Date:  1984-01       Impact factor: 5.790

10.  Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients.

Authors:  J M Prins; G J Weverling; R J van Ketel; P Speelman
Journal:  Clin Pharmacol Ther       Date:  1997-07       Impact factor: 6.875

View more
  10 in total

1.  Pharmacologic Basis for the Treatment of Pyelonephritis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

2.  Prevention of Renal Scarring in Acute Pyelonephritis by Probiotic Therapy: an Experimental Study.

Authors:  Nastaran Sabetkish; Shabnam Sabetkish; Mohammad Javad Mohseni; Abdol-Mohammad Kajbafzadeh
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

3.  The effect of vitamin A on renal damage following acute pyelonephritis in children.

Authors:  Parviz Ayazi; Seyed Alireza Moshiri; Abolfazl Mahyar; Mona Moradi
Journal:  Eur J Pediatr       Date:  2010-09-18       Impact factor: 3.183

Review 4.  Timing is everything: impact of development, ageing and circadian rhythm on macrophage functions in urinary tract infections.

Authors:  Alison S Wang; Nicholas J Steers; Adwaita R Parab; Frédéric Gachon; Matthew J Sweet; Indira U Mysorekar
Journal:  Mucosal Immunol       Date:  2022-08-29       Impact factor: 8.701

5.  Vitamin E administration at the onset of fever prevents renal scarring in acute pyelonephritis.

Authors:  Zhina Sadeghi; Abdol-Mohammad Kajbafzadeh; Parvin Tajik; Maryam Monajemzadeh; Seyedmehdi Payabvash; Azadeh Elmi
Journal:  Pediatr Nephrol       Date:  2008-06-04       Impact factor: 3.714

6.  Interaction between gentamicin and mycophenolate mofetil in experimentally induced pyelonephritis.

Authors:  H Malekinejad; A Nikibakhsh; S Gholizadeh-Soltani; A Farshid
Journal:  Indian J Nephrol       Date:  2012-01

7.  Development of a mouse model of ascending infection and preterm birth.

Authors:  Nicholas R Spencer; Enkhtuya Radnaa; Tuvshintugs Baljinnyam; Talar Kechichian; Ourlad Alzeus G Tantengco; Elizabeth Bonney; Ananth Kumar Kammala; Samantha Sheller-Miller; Ramkumar Menon
Journal:  PLoS One       Date:  2021-12-02       Impact factor: 3.240

8.  Effects on Tissue Integration of Collagen Scaffolds Used for Local Delivery of Gentamicin in a Rat Mandible Defect Model.

Authors:  Caroline Billings; Austin J Bow; Steven D Newby; Robert L Donnell; Madhu Dhar; David E Anderson
Journal:  Bioengineering (Basel)       Date:  2022-06-24

9.  Renoprotective effects of Andrographis paniculata (Burm. f.) Nees in rats.

Authors:  Pratibha Singh; Man Mohan Srivastava; Lakhu Dev Khemani
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

10.  Daily rhythms of both host and parasite affect antimalarial drug efficacy.

Authors:  Alíz T Y Owolabi; Sarah E Reece; Petra Schneider
Journal:  Evol Med Public Health       Date:  2021-04-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.